← FDA DRUG APPROVALS

FDA ANDA · ANDA072995

METOCLOPRAMIDE INTENSOL

Sponsor: ROXANE

APPLICATION
ANDA072995
TYPE
ANDA
ORIGINAL APPROVAL
1992-01-30
LATEST ACTION
1998-04-01
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE INTENSOLDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE/ML · CONCENTRATE · ORAL

Approval history

1998-04-01Labeling · Supplement 2AP
1996-08-28Manufacturing (CMC) · Supplement 1AP
1992-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →